Oral Squamous Cell Carcinoma in Young Patients Show Higher Rates of EGFR Amplification: Implications for Novel Personalized Therapy

There is an increasing worldwide incidence of patients under 50 years of age presenting with oral squamous cell carcinoma (OSCC). The molecular mechanisms driving disease in this emerging cohort remain unclear, limiting impactful treatment options for these patients. To identify common clinically ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Satgunaseelan, Laveniya, Porazinski, Sean, Strbenac, Dario, Istadi, Aji, Willet, Cali, Chew, Tracy, Sadsad, Rosemarie, Palme, Carsten E., Lee, Jenny H., Boyer, Michael, Yang, Jean Y. H., Clark, Jonathan R., Pajic, Marina, Gupta, Ruta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666981/
https://www.ncbi.nlm.nih.gov/pubmed/34912708
http://dx.doi.org/10.3389/fonc.2021.750852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666981/
https://www.ncbi.nlm.nih.gov/pubmed/34912708
http://dx.doi.org/10.3389/fonc.2021.750852

Ejemplares similares